IRD Opus Genetics, Inc.: institutional ownership and insider trading
107 funds reported holding $241M of Opus Genetics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $49.3M, with 39 new positions and 16 funds selling out; over the last 12 months insiders bought $324K and sold $19.3M on the open market; over its last four quarters it reported revenue of $9.86M and net income of −$108M.
IRD revenue and earnings
- Quarter ended Jun 30, 2026: revenue $755K, net income −$8.10M, EPS -0.14
- Quarter ended Mar 31, 2026: revenue $2.16M, net income −$65.5M, EPS -0.75
- Quarter ended Dec 31, 2025: revenue $3.87M, net income −$16.5M, EPS -0.19
- Quarter ended Sep 30, 2025: revenue $3.08M, net income −$17.5M, EPS -0.25
Famous investors holding IRD
- Izzy Englander (Millennium Management): $9.46M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.74M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.04M, 0.0% of the portfolio
Largest institutional holders of IRD
- Caligan Partners LP — $25.0M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $24.8M
- BIOS Capital Management, LP — $15.1M
- BlackRock, Inc. (BLK) — $12.8M
- BALYASNY ASSET MANAGEMENT L.P. — $12.7M
- Nantahala Capital Management, LLC — $12.6M
- VANGUARD CAPITAL MANAGEMENT LLC — $12.2M
- Boxer Capital Management, LLC — $11.6M
- Trails Edge Capital Partners, LP — $11.3M
- MILLENNIUM MANAGEMENT LLC — $9.46M
Recent IRD insider trades
- Sep 30, 2026: Foundation Fighting Blindness Retinal Degeneration Fund sold 556,000 shares ($2.76M)
- Sep 3, 2026: Gagnon Robert E. sold 28,000 shares ($127K)
- Jul 23, 2026: Gagnon Robert E. sold 7,783 shares ($23.0K)
- Jul 23, 2026: Magrath George sold 9,475 shares ($28.0K)
5%+ owners
- Perceptive Advisors LLC: 10.0% (Schedule 13G/A, filed Aug 14, 2026)
- Adage Capital Management, L.P.: 8.5% (Schedule 13G, filed May 13, 2026)
- Caligan Partners LP: 7.3% (Schedule 13G/A, filed Aug 14, 2026)
- BALYASNY ASSET MANAGEMENT L.P.: 6.6% (Schedule 13G/A, filed Aug 14, 2026)
- Nantahala Capital Management, LLC: 6.5% (Schedule 13G/A, filed May 15, 2026)
Who owns the most IRD stock?
The largest institutional holders of Opus Genetics, Inc. in the latest 13F filings are Caligan Partners LP ($25.0M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($24.8M), BIOS Capital Management, LP ($15.1M).
Are insiders buying or selling IRD?
Over the last 12 months insiders bought $324K and sold $19.3M of Opus Genetics, Inc. stock on the open market (SEC Form 4).
Which famous investors own IRD?
Izzy Englander, Ken Griffin, Two Sigma.
What was IRD's revenue last quarter?
Opus Genetics, Inc. reported revenue of $755K for the quarter ended June 30, 2026, with net income of −$8.10M.